These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8217128)

  • 21. Alternating Unilateral Versus Bilateral Injections of Botulinum Toxin for the Treatment of Adductor Spasmodic Dysphonia.
    Lee SJ; Kang MS; Choi HS; Lim JY
    Otolaryngol Head Neck Surg; 2021 Apr; 164(4):815-820. PubMed ID: 32957836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technique for injection of botulinum toxin through the flexible nasolaryngoscope.
    Rhew K; Fiedler DA; Ludlow CL
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):787-94. PubMed ID: 7991260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
    Ludlow CL; Naunton RF; Terada S; Anderson BJ
    Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.
    Murry T; Woodson GE
    J Voice; 1995 Dec; 9(4):460-5. PubMed ID: 8574315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
    Davidson BJ; Ludlow CL
    Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.
    Inagi K; Ford CN; Bless DM; Heisey D
    J Voice; 1996 Sep; 10(3):306-13. PubMed ID: 8865102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia.
    Green DC; Berke GS; Ward PH; Gerratt BR
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):883-7. PubMed ID: 1444094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
    Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
    Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of botulinum toxin on vocal tract steadiness in patients with spasmodic dysphonia.
    Zwirner P; Murry T; Woodson GE
    Eur Arch Otorhinolaryngol; 1997; 254(8):391-5. PubMed ID: 9332896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.
    Mehta RP; Goldman SN; Orloff LA
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):393-9. PubMed ID: 11296047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spasmodic dysphonia. Investigation and therapeutic methods].
    Marion MH; Klap P; Perrin A; Elbaz E
    Rev Neurol (Paris); 1992; 148(3):180-3. PubMed ID: 1604131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined modality treatment of adductor spasmodic dysphonia.
    Silverman EP; Garvan C; Shrivastav R; Sapienza CM
    J Voice; 2012 Jan; 26(1):77-86. PubMed ID: 21292439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
    J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternating unilateral botulinum toxin type A (BOTOX) injections for spasmodic dysphonia.
    Koriwchak MJ; Netterville JL; Snowden T; Courey M; Ossoff RH
    Laryngoscope; 1996 Dec; 106(12 Pt 1):1476-81. PubMed ID: 8948606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.
    Bielamowicz S; Stager SV; Badillo A; Godlewski A
    J Voice; 2002 Mar; 16(1):117-23. PubMed ID: 12002878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.